Filters

K Wallendszus

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Hepatopathy-thrombocytopenia syndrome--a complication of dactinomycin therapy for Wilms' tumor: a report from the United Kingdom Childrens Cancer Study GroupJ Raine, A Bowman, K Wallendszus, et al.
BMJ (Clinical Research Ed.)|July 13, 1996
Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study GroupJ Wardle, J Armitage, R Collins, et al.
European Heart Journal|February 1, 1994
Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality studyA Keech, R Collins, S MacMahon, et al.
American Heart Journal|April 30, 2017
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics, L Bowman, F Chen, et al.
European Heart Journal|December 15, 2021
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease, , E Sammons, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Hepatopathy-thrombocytopenia syndrome--a complication of dactinomycin therapy for Wilms' tumor: a report from the United Kingdom Childrens Cancer Study GroupJ Raine, A Bowman, K Wallendszus, et al.
BMJ (Clinical Research Ed.)|July 13, 1996
Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study GroupJ Wardle, J Armitage, R Collins, et al.
European Heart Journal|February 1, 1994
Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality studyA Keech, R Collins, S MacMahon, et al.
American Heart Journal|April 30, 2017
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics, L Bowman, F Chen, et al.
European Heart Journal|December 15, 2021
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease, , E Sammons, et al.
Pageof 1
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us